Kerrisdale and Steamboat Send Letter to ACM Research Inc.
The full text of the letter follows:
Chief Executive Officer
ACM Research, Inc.
cc: Board of Directors
Kerrisdale Capital Management, LLC, Steamboat Capital Partners LLC and our respective affiliates collectively own or advise entities owning approximately 600,000 shares of ACM Research, Inc.
We are excited to hear that management is taking preliminary steps to pursue a
We think that the issuance of publicly tradable shares of ACM Research (Shanghai), Inc. on the Hong Kong Stock Exchange is a step in the right direction to address the share discount of ACMR, among other benefits.
Tradable shares on an Asian exchange accessible to global investors can provide a variety of potential opportunities to pursue financial transactions and corporate actions that can not only reduce the discount that ACMR trades at, but potentially eliminate it.
Additionally, the company could also, or could instead, pursue a public offering and listing in
We are writing this letter to communicate that we would be interested in being an anchor investor in such a public offering of
Even if you do not pursue an offering and listing of ACM Research, Inc. shares in
Let's go to
Thank you.
Sincerely,
Chief Investment Officer
Kerrisdale Capital Management, LLC
Managing Partner
Steamboat Capital Partners LLC
Media contact:
[email protected]
[email protected]
View original content:https://www.prnewswire.com/news-releases/kerrisdale-and-steamboat-send-letter-to-acm-research-inc-302750265.html
SOURCE Kerrisdale Capital Management, LLC and Steamboat Capital Partners LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Times: How Chinese NEVs gain ground in global markets, providing greener, smarter mobility
- ATTACK SHARK Unveils R86 HE Carbon Fiber Magnetic Switch Gaming Keyboard, Redefining the 75% Competitive Keyboard Experience
- Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight Management
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Kerrisdale CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share